Track & Trace

The manufacture of validation batches has begun, with release and shipping to Korea expected in mid-March 2015. Recipharm stated in a press release that cost was kept to a minimum for this serialization project and full implementation was achieved. Recipharm is expecting to roll out further projects during the year.

Late last year it was announced that Barra Funda, Brazil-based Libbs Farmacêutica Ltda., a maker of pharmaceuticals, biotechnology and biosimilar drugs, was involved in a project aimed at addressing aggregation and track-and-trace requirements posed by the Agência National de Vigilância Sanitária Agency (ANVISA).
Aimed at addressing pharmaceutical security in Brazil, ANVISA regulations require packaging units to be marked with a serial number, product registration identification, GTIN, lot number, date of production, expiry date as well as a DataMatrix code encoded with these details, providing a trail of the unit through the logistics chain, from a single box to a pallet, including the companies involved.

This article describes the installation of Antares Tracking System (ATS), an advanced traceability solution from Antares Vision, at the largest pharmaceutical manufacturing plant and the biggest distribution center in all of Turkey, both of which are owned by a major multinational pharmaceutical company. These two projects were carried out in parallel and coordinated with each other. Their size, timing of implementation, and successful results have made them a benchmark of the marketplace.

A new regulation determining serialization was introduced by the Chinese regulatory authority with strict importation deadlines set in place offering zero flexibility on full compliance.
Recipharm developed an adaptable solution using a meticulous and methodical approach proven to ensure full and complete compliance in which 57 serialized batches have been supplied since Feb. 2014.

Drug theft, diversion and counterfeiting – pharmaceutical companies face a number of critical, potentially damaging challenges with their supply chain. Track & Trace (T&T) is a new solution that can help pharma companies mitigate these risks and optimize their supply chain.

With IBM Control Center 6, we are introducing the next step in the evolution of track and trace solutions. I say it’s the next step in the evolution because as a category of software solutions, monitoring is on the brink of some pretty rapid transformation. And the changes that you see on the surface in Control Center 6 are mirrored by foundational changes occurring under the covers that are leading us to tomorrow.

Recipharm, a contract development and manufacturing organization, announced its readiness for serialization after completion of a complex serialization project for China on behalf of one of its customers.

Late last year it was announced that Barra Funda, Brazil-based Libbs Farmacêutica Ltda., a maker of pharmaceuticals, biotechnology and biosimilar drugs, was involved in a project aimed at addressing aggregation and track-and-trace requirements posed by the Agência National de Vigilância Sanitária Agency (ANVISA).

Our goal is to provide you with powerful examples of how industry stakeholders from small, mid and large pharmaceutical companies, wholesalers and retailers have taken proactive steps to implement the latest strategies for traceability within their organizations.

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant obstacles, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.

Since the installation of its first track and trace system in 2008, Antares Vision has become a technology front runner for pharmaceutical inspection systems and a leader in complete hardware and software solutions for pharmaceutical serialization and track and trace.